National Cancer Institute, Naples

This early-phase trial tests a cancer vaccine (IMA970A) plus an immunotherapy drug (durvalumab) in 10 people with early-stage liver cancer who have already had standard treatments. The goal is to see if the combination is safe and can lower the chance of the cancer returning. Par…

This study looks at how well men with intermediate-risk prostate cancer recover their erectile function and quality of life after stopping hormone therapy and receiving radiotherapy. About 50 men will take a hormone drug (Relugolix) followed by radiation, then fill out questionna…